BioMarin Pharmaceutical Inc. (LON:0HNC)
58.73
+0.39 (0.66%)
At close: May 29, 2025
BioMarin Pharmaceutical Employees
BioMarin Pharmaceutical had 3,040 employees as of December 31, 2024. The number of employees decreased by 361 or -10.61% compared to the previous year.
Employees
3,040
Change (1Y)
-361
Growth (1Y)
-10.61%
Revenue / Employee
751.13K GBP
Profits / Employee
133.38K GBP
Market Cap
8.27B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
BioMarin Pharmaceutical News
- 7 days ago - INOZYME PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inozyme Pharma, Inc. - INZY - Business Wire
- 10 days ago - BioMarin: Inozyme Acquisition Falls Short Of Offsetting Looming Revenue Risks (Downgrade) - Seeking Alpha
- 13 days ago - BioMarin Bolsters Pipeline With $270 Million Inozyme Pharma Takeover - Investor's Business Daily
- 13 days ago - BioMarin to buy enzyme therapy developer Inozyme in $270M all-cash deal - Seeking Alpha
- 13 days ago - BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma - PRNewsWire
- 17 days ago - BioMarin Presents New Data for VOXZOGO® (vosoritide) in Children with Achondroplasia and Other Skeletal Conditions at Two International Endocrinology Meetings - PRNewsWire
- 27 days ago - A Look Into Biomarin Pharmaceutical Inc's Price Over Earnings - Benzinga
- 27 days ago - BioMarin outlines 2025 revenue growth with VOXZOGO expected to reach $950M - Seeking Alpha